427 related articles for article (PubMed ID: 2425498)
21. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
Lipka K; Tebbe B; Finckh U; Rolfs A
Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of human lymphotrophic retroviruses: an overview.
Blattner WA; Biggar RJ; Weiss SH; Clark JW; Goedert JJ
Cancer Res; 1985 Sep; 45(9 Suppl):4598s-4601s. PubMed ID: 2990691
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
[TBL] [Abstract][Full Text] [Related]
24. A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome.
Gallo RC; Wong-Staal F
Ann Intern Med; 1985 Nov; 103(5):679-89. PubMed ID: 2996399
[TBL] [Abstract][Full Text] [Related]
25. Retroviruses: new viral infections in man.
Salahuddin SZ; Markham PD
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S107-19. PubMed ID: 2899867
[TBL] [Abstract][Full Text] [Related]
26. Heteroduplex mapping in the molecular analysis of the human T-cell leukemia (lymphotropic) viruses.
Gonda MA; Wong-Staal F; Gallo RC; Clements JE; Gilden RV
Cancer Res; 1985 Sep; 45(9 Suppl):4553s-4558s. PubMed ID: 2990686
[TBL] [Abstract][Full Text] [Related]
27. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
28. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
29. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
30. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
Mitsuya H; Matsushita S; Yarchoan R; Broder S
Princess Takamatsu Symp; 1984; 15():277-88. PubMed ID: 6085846
[TBL] [Abstract][Full Text] [Related]
31. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.
Chandra P; Vogel A; Gerber T
Cancer Res; 1985 Sep; 45(9 Suppl):4677s-4684s. PubMed ID: 2410112
[TBL] [Abstract][Full Text] [Related]
33. T cell malignancies and human T cell leukemia (lymphotropic) retroviruses (HTLV).
Sarin PS; Gallo RC
Prog Clin Biol Res; 1985; 184():445-56. PubMed ID: 2996018
[No Abstract] [Full Text] [Related]
34. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
35. Expression of AIDS virus envelope gene in recombinant vaccinia viruses.
Hu SL; Kosowski SG; Dalrymple JM
Nature; 1986 Apr 10-16; 320(6062):537-40. PubMed ID: 3008002
[TBL] [Abstract][Full Text] [Related]
36. Lymphadenopathy associated virus and its etiological role in AIDS.
Montagnier L; Chermann JC; Barré-Sinoussi F; Klatzmann D; Wain-Hobson S; Alizon M; Clavel F; Brun-Vezinet F; Vilmer E; Rouzioux C
Princess Takamatsu Symp; 1984; 15():319-31. PubMed ID: 6100650
[TBL] [Abstract][Full Text] [Related]
37. Production of oncogene-specific proteins and human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein in bacteria and its potential for use in human cancers and seroepidemiological surveys.
Papas TS; Samuel KP; Kan NC; Ascione R; Wong-Staal F; Lautenberger JA
Cancer Res; 1985 Sep; 45(9 Suppl):4568s-4573s. PubMed ID: 2861893
[TBL] [Abstract][Full Text] [Related]
38. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
39. Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro.
Hahn B; Gallo RC; Franchini G; Popovic M; Aoki T; Salahuddin SZ; Markham PD; Staal FW
Mol Biol Med; 1984 Feb; 2(1):29-36. PubMed ID: 6096666
[TBL] [Abstract][Full Text] [Related]
40. [A new HTLV retrovirus associated with human T-cell leukemia/lymphoma].
Kiselev FL
Eksp Onkol; 1984; 6(3):3-9. PubMed ID: 6094144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
